Single-Cell Transcriptome Integration Analysis Reveals the Correlation Between Mesenchymal Stromal Cells and Fibroblasts
- PMID: 35360851
- PMCID: PMC8961367
- DOI: 10.3389/fgene.2022.798331
Single-Cell Transcriptome Integration Analysis Reveals the Correlation Between Mesenchymal Stromal Cells and Fibroblasts
Abstract
Background: Mesenchymal stromal cells (MSCs) and fibroblasts show similar morphology, surface marker expression, and proliferation, differentiation, and immunomodulatory capacities. These similarities not only blur their cell identities but also limit their application. Methods: We performed single-cell transcriptome sequencing of the human umbilical cord and foreskin MSCs (HuMSCs and FSMSCs) and extracted the single-cell transcriptome data of the bone marrow and adipose MSCs (BMSCs and ADMSCs) from the Gene Expression Omnibus (GEO) database. Then, we performed quality control, batch effect correction, integration, and clustering analysis of the integrated single-cell transcriptome data from the HuMSCs, FMSCs, BMSCs, and ADMSCs. The cell subsets were annotated based on the surface marker phenotypes for the MSCs (CD105 + , CD90 +, CD73 +, CD45 -, CD34 -, CD19 -, HLA-DRA -, and CD11b -), fibroblasts (VIM +, PECAM1 -, CD34 -, CD45 -, EPCAM -, and MYH11 -), and pericytes (CD146 +, PDGFRB +, PECAM1 -, CD34 -, and CD45 -). The expression levels of common fibroblast markers (ACTA2, FAP, PDGFRA, PDGFRB, S100A4, FN1, COL1A1, POSTN, DCN, COL1A2, FBLN2, COL1A2, DES, and CDH11) were also analyzed in all cell subsets. Finally, the gene expression profiles, differentiation status, and the enrichment status of various gene sets and regulons were compared between the cell subsets. Results: We demonstrated 15 distinct cell subsets in the integrated single-cell transcriptome sequencing data. Surface marker annotation demonstrated the MSC phenotype in 12 of the 15 cell subsets. C10 and C14 subsets demonstrated both the MSC and pericyte phenotypes. All 15 cell subsets demonstrated the fibroblast phenotype. C8, C12, and C13 subsets exclusively demonstrated the fibroblast phenotype. We identified 3,275 differentially expressed genes, 305 enriched gene sets, and 34 enriched regulons between the 15 cell subsets. The cell subsets that exclusively demonstrated the fibroblast phenotype represented less primitive and more differentiated cell types. Conclusion: Cell subsets with the MSC phenotype also demonstrated the fibroblast phenotype, but cell subsets with the fibroblast phenotype did not necessarily demonstrate the MSC phenotype, suggesting that MSCs represented a subclass of fibroblasts. We also demonstrated that the MSCs and fibroblasts represented highly heterogeneous populations with distinct cell subsets, which could be identified based on the differentially enriched gene sets and regulons that specify proliferating, differentiating, metabolic, and/or immunomodulatory functions.
Keywords: fibroblast; integration analysis; mesenchymal stromal cells; pericytes; single-cell transcriptome sequencing.
Copyright © 2022 Fan, Liao, Xie, Huang, Lv, Cai, Su, Wang, Wang, Wang, Liu, Wang, Guo, Yang, Liu, Wang and Ma.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
Single-cell RNA sequencing reveals the potential mechanism of heterogeneity of immunomodulatory properties of foreskin and umbilical cord mesenchymal stromal cells.Cell Biosci. 2022 Jul 22;12(1):115. doi: 10.1186/s13578-022-00848-w. Cell Biosci. 2022. PMID: 35869528 Free PMC article.
-
Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts.Exp Hematol. 2008 May;36(5):642-54. doi: 10.1016/j.exphem.2007.12.015. Epub 2008 Mar 4. Exp Hematol. 2008. PMID: 18295964
-
Perivascular human endometrial mesenchymal stem cells express pathways relevant to self-renewal, lineage specification, and functional phenotype.Biol Reprod. 2012 Feb 29;86(2):58. doi: 10.1095/biolreprod.111.095885. Print 2012 Feb. Biol Reprod. 2012. PMID: 22075475 Free PMC article.
-
Endometrial stem/progenitor cells: the first 10 years.Hum Reprod Update. 2016 Mar-Apr;22(2):137-63. doi: 10.1093/humupd/dmv051. Epub 2015 Nov 9. Hum Reprod Update. 2016. PMID: 26552890 Free PMC article. Review.
-
Epithelial In vitro Differentiation of Mesenchymal Stem Cells.Curr Stem Cell Res Ther. 2018;13(6):409-422. doi: 10.2174/1574888X13666180501120416. Curr Stem Cell Res Ther. 2018. PMID: 29714147 Review.
Cited by
-
Targeting stromal cells in tumor microenvironment as a novel treatment strategy for glioma.Cancer Cell Int. 2025 Feb 21;25(1):58. doi: 10.1186/s12935-025-03692-3. Cancer Cell Int. 2025. PMID: 39985022 Free PMC article. Review.
-
Development and characterization of a novel immortalized human vaginal fibroblast cell line for advanced applications in reproductive health.Reprod Biol Endocrinol. 2025 Apr 10;23(1):56. doi: 10.1186/s12958-025-01393-0. Reprod Biol Endocrinol. 2025. PMID: 40211367 Free PMC article.
-
Identifying differentiation markers between dermal fibroblasts and adipose-derived mesenchymal stromal cells (AD-MSCs) in human visceral and subcutaneous tissues using single-cell transcriptomics.Stem Cell Res Ther. 2025 Feb 11;16(1):64. doi: 10.1186/s13287-025-04185-w. Stem Cell Res Ther. 2025. PMID: 39934849 Free PMC article.
-
Gene Coexpression Network Characterizing Microenvironmental Heterogeneity and Intercellular Communication in Pancreatic Ductal Adenocarcinoma: Implications of Prognostic Significance and Therapeutic Target.Front Oncol. 2022 Jun 1;12:840474. doi: 10.3389/fonc.2022.840474. eCollection 2022. Front Oncol. 2022. PMID: 35719923 Free PMC article.
-
Mesothelioma cell heterogeneity identified by single cell RNA sequencing.Sci Rep. 2025 Mar 13;15(1):8725. doi: 10.1038/s41598-025-92542-3. Sci Rep. 2025. PMID: 40082554 Free PMC article.
References
-
- Bhansali S., Dutta P., Kumar V., Yadav M. K., Jain A., Mudaliar S., et al. (2017). Efficacy of Autologous Bone Marrow-Derived Mesenchymal Stem Cell and Mononuclear Cell Transplantation in Type 2 Diabetes Mellitus: A Randomized, Placebo-Controlled Comparative Study. Stem Cell Dev. 26 (7), 471–481. 10.1089/scd.2016.0275 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous